118 related articles for article (PubMed ID: 2064826)
1. Vaccine protection against HIV-2 infection in cynomolgus monkeys.
Putkonen P; Thorstensson R; Walther L; Albert J; Akerblom L; Granquist O; Wadell G; Norrby E; Biberfeld G
AIDS Res Hum Retroviruses; 1991 Mar; 7(3):271-7. PubMed ID: 2064826
[TBL] [Abstract][Full Text] [Related]
2. Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine.
Putkonen P; Björling E; Akerblom L; Thorstensson R; Lövgren K; Benthin L; Chiodi F; Morein B; Biberfeld G; Norrby E
J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):551-9. PubMed ID: 8176640
[TBL] [Abstract][Full Text] [Related]
3. Protection of cynomolgus macaques (Macaca fascicularis) against infection with the human immunodeficiency virus type 2 strain ben (HIV-2ben) by immunization with the virion-derived envelope glycoprotein gp130.
Lüke W; Voss G; Stahl-Hennig C; Coulibaly C; Putkonen P; Petry H; Hunsmann G
AIDS Res Hum Retroviruses; 1993 May; 9(5):387-94. PubMed ID: 8318267
[TBL] [Abstract][Full Text] [Related]
4. Prevention of HIV-2 and SIVSM infection in cynomolgus monkeys by active or passive immunization.
Biberfield G; Putkonen P; Thorstensson R; Norrby E
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1511-3. PubMed ID: 1466992
[TBL] [Abstract][Full Text] [Related]
5. Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys.
Walther-Jallow L; Nilsson C; Söderlund J; Ten Haaft P; Mäkitalo B; Biberfeld P; Böttiger P; Heeney J; Biberfeld G; Thorstensson R
J Gen Virol; 2001 Jul; 82(Pt 7):1601-1612. PubMed ID: 11413371
[TBL] [Abstract][Full Text] [Related]
6. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm.
Nilsson C; Mäkitalo B; Thorstensson R; Norley S; Binninger-Schinzel D; Cranage M; Rud E; Biberfeld G; Putkonen P
AIDS; 1998 Dec; 12(17):2261-70. PubMed ID: 9863867
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeys.
Andersson S; Mäkitalo B; Thorstensson R; Franchini G; Tartaglia J; Limbach K; Paoletti E; Putkonen P; Biberfeld G
J Infect Dis; 1996 Nov; 174(5):977-85. PubMed ID: 8896498
[TBL] [Abstract][Full Text] [Related]
8. Vaccine protection against simian immunodeficiency virus infection.
Desrosiers RC; Wyand MS; Kodama T; Ringler DJ; Arthur LO; Sehgal PK; Letvin NL; King NW; Daniel MD
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6353-7. PubMed ID: 2548210
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
10. Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys.
Putkonen P; Thorstensson R; Ghavamzadeh L; Albert J; Hild K; Biberfeld G; Norrby E
Nature; 1991 Aug; 352(6334):436-8. PubMed ID: 1677743
[TBL] [Abstract][Full Text] [Related]
11. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
Carlson JR; McGraw TP; Keddie E; Yee JL; Rosenthal A; Langlois AJ; Dickover R; Donovan R; Luciw PA; Jennings MB
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1239-46. PubMed ID: 2078406
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5).
Hulskotte EG; Geretti AM; Siebelink KH; van Amerongen G; Cranage MP; Rud EW; Norley SG; de Vries P; Osterhaus AD
J Virol; 1995 Oct; 69(10):6289-96. PubMed ID: 7666529
[TBL] [Abstract][Full Text] [Related]
13. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines.
Rimmelzwaan GF; Baars M; van Beek R; van Amerongen G; Lövgren-Bengtsson K; Claas EC; Osterhaus AD
J Gen Virol; 1997 Apr; 78 ( Pt 4)():757-65. PubMed ID: 9129647
[TBL] [Abstract][Full Text] [Related]
14. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
[TBL] [Abstract][Full Text] [Related]
15. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine.
Putkonen P; Walther L; Zhang YJ; Li SL; Nilsson C; Albert J; Biberfeld P; Thorstensson R; Biberfeld G
Nat Med; 1995 Sep; 1(9):914-8. PubMed ID: 7585217
[TBL] [Abstract][Full Text] [Related]
16. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of inactivated whole HIV-2 vaccines with various adjuvants in cynomolgus monkeys.
Putkonen P; Nilsson C; Walther L; Ghavamzadeh L; Hild K; Broliden K; Biberfeld G; Thorstensson R
J Med Primatol; 1994; 23(2-3):89-94. PubMed ID: 7966239
[TBL] [Abstract][Full Text] [Related]
18. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
19. Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection.
Putkonen P; Thorstensson R; Albert J; Hild K; Norrby E; Biberfeld P; Biberfeld G
AIDS; 1990 Aug; 4(8):783-9. PubMed ID: 1979745
[TBL] [Abstract][Full Text] [Related]
20. A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.
Ferrantelli F; Maggiorella MT; Schiavoni I; Sernicola L; Olivieri E; Farcomeni S; Pavone-Cossut MR; Moretti S; Belli R; Collacchi B; Srivastava IK; Titti F; Cafaro A; Barnett SW; Ensoli B
Vaccine; 2011 Apr; 29(16):2918-32. PubMed ID: 21338681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
